| RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response MA Hofmann, S Drury, BI Hudson, MR Gleason, W Qu, Y Lu, E Lalla, ... Genes & Immunity 3 (3), 123-135, 2002 | 496 | 2002 |
| Identification, classification, and expression of RAGE gene splice variants BI Hudson, AM Carter, E Harja, AZ Kalea, M Arriero, H Yang, PJ Grant, ... The FASEB Journal 22 (5), 1572-1580, 2008 | 466 | 2008 |
| Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE–/– mice E Harja, D Bu, BI Hudson, JS Chang, X Shen, K Hallam, AZ Kalea, Y Lu, ... The Journal of clinical investigation 118 (1), 183-194, 2008 | 461 | 2008 |
| Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42 BI Hudson, AZ Kalea, M del Mar Arriero, E Harja, E Boulanger, V D'Agati, ... Journal of Biological Chemistry 283 (49), 34457-34468, 2008 | 405 | 2008 |
| Targeting RAGE signaling in inflammatory disease BI Hudson, ME Lippman Annual review of medicine 69, 349-364, 2018 | 394 | 2018 |
| Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropath: y T Wendt, N Tanji, J Guo, BI Hudson, A Bierhaus, R Ramasamy, B Arnold, ... Journal of the American Society of Nephrology 14 (5), 1383-1395, 2003 | 353 | 2003 |
| Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy BI Hudson, MH Stickland, TS Futers, PJ Grant Diabetes 50 (6), 1505-1511, 2001 | 341 | 2001 |
| Composite scaffold provides a cell delivery platform for cardiovascular repair AFG Godier-Furnémont, TP Martens, MS Koeckert, L Wan, J Parks, K Arai, ... Proceedings of the National Academy of Sciences 108 (19), 7974-7979, 2011 | 311 | 2011 |
| The RAGE axis in early diabetic retinopathy GR Barile, SI Pachydaki, SR Tari, SE Lee, CM Donmoyer, W Ma, LL Rong, ... Investigative ophthalmology & visual science 46 (8), 2916-2924, 2005 | 290 | 2005 |
| Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders BI Hudson, LG Bucciarelli, T Wendt, T Sakaguchi, E Lalla, W Qu, Y Lu, ... Archives of biochemistry and biophysics 419 (1), 80-88, 2003 | 234 | 2003 |
| Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases H Maillard-Lefebvre, E Boulanger, M Daroux, C Gaxatte, BI Hudson, ... Rheumatology 48 (10), 1190-1196, 2009 | 227 | 2009 |
| RAGE: a novel biological and genetic marker for vascular disease AZ Kalea, AM Schmidt, BI Hudson Clinical Science 116 (8), 621-637, 2009 | 226 | 2009 |
| Prevalence in Type 2 Diabetes and Ethnic Groups BI Hudson, MH Stickland, PJ Grant Diabetes 47, 1155, 1998 | 206 | 1998 |
| Percutaneous cell delivery into the heart using hydrogels polymerizing in situ TP Martens, AFG Godier, JJ Parks, LQ Wan, MS Koeckert, GM Eng, ... Cell transplantation 18 (3), 297-304, 2009 | 181 | 2009 |
| The functional− 374 T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients K Pettersson-Fernholm, C Forsblom, BI Hudson, M Perola, PJ Grant, ... Diabetes 52 (3), 891-894, 2003 | 177 | 2003 |
| Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis BIH T Kwak, K Drews-Elger, A Ergonul, P C Miller, A Braley, G H Hwang, D ... Oncogene 36, 1559-1572, 2017 | 136 | 2017 |
| Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene AZ Kalea, N Reiniger, H Yang, M Arriero, AM Schmidt, BI Hudson The FASEB journal 23 (6), 1766, 2009 | 134 | 2009 |
| RAGE ligand upregulation of VEGF secretion in ARPE-19 cells W Ma, SE Lee, J Guo, W Qu, BI Hudson, AM Schmidt, GR Barile Investigative ophthalmology & visual science 48 (3), 1355-1361, 2007 | 134 | 2007 |
| Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesis W Kim, BI Hudson, B Moser, J Guo, LL Rong, YAN Lu, WU Qu, E Lalla, ... Annals of the New York Academy of Sciences 1043 (1), 553-561, 2005 | 134 | 2005 |
| RAGE: a novel target for drug intervention in diabetic vascular disease BI Hudson, AM Schmidt Pharmaceutical research 21, 1079-1086, 2004 | 123 | 2004 |
Anastasia Z. Kalea, PhDUCL Division of MedicineE-mail confirmado em ucl.ac.uk
